{
    "2021-01-26": [
        [
            {
                "time": "",
                "original_text": "药明康德现3笔大宗交易，共成交6,143.14万元",
                "features": {
                    "keywords": [
                        "药明康德",
                        "大宗交易",
                        "成交"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "大和：上调药明康德(02359)目标价36.8%至238港元，评级“跑赢大市”",
                "features": {
                    "keywords": [
                        "药明康德",
                        "上调",
                        "目标价",
                        "跑赢大市"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "部分明星股日内跌势不止，迈瑞医疗、药明康德、分众传媒均下挫逾7%",
                "features": {
                    "keywords": [
                        "明星股",
                        "跌势",
                        "迈瑞医疗",
                        "药明康德",
                        "分众传媒"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "广告传媒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医疗健康行业基金4Q分析：四季度医药板块配置环比下降，机构持仓名义集中",
                "features": {
                    "keywords": [
                        "医疗健康",
                        "基金",
                        "医药板块",
                        "配置下降",
                        "机构持仓"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药行业Q42020持仓分析：医药仓位有所回落，核心资产持续加强",
                "features": {
                    "keywords": [
                        "医药行业",
                        "持仓分析",
                        "仓位回落",
                        "核心资产"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "“药明系”股价再创新高，市值已突破万亿港元",
                "features": {
                    "keywords": [
                        "药明系",
                        "股价新高",
                        "市值突破"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "港股生物医药板块集体下挫，泰格医药跌5.9%，康希诺生物跌5.2%，药明康德跌5.1%，药明生物跌4.8%，百济神州跌4%\n连续下跌",
                "features": {
                    "keywords": [
                        "港股",
                        "生物医药",
                        "集体下挫",
                        "泰格医药",
                        "康希诺生物",
                        "药明康德",
                        "药明生物",
                        "百济神州"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "大和升药明康德(02359-HK)目标价至238港元升去年纯利预测",
                "features": {
                    "keywords": [
                        "大和",
                        "药明康德",
                        "目标价",
                        "纯利预测"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "更快、更多、更好，下一个创新领域在哪里？| 药明康德全球论坛实录",
                "features": {
                    "keywords": [
                        "创新领域",
                        "药明康德",
                        "全球论坛"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【山证医药】医药行业周报（20210123）：业绩预告密集发布，持续关注高景气细分领域",
                "features": {
                    "keywords": [
                        "山证医药",
                        "医药行业",
                        "周报",
                        "业绩预告",
                        "高景气细分领域"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中信建投五大研究团队复盘2020年四季度公募基金持仓",
                "features": {
                    "keywords": [
                        "中信建投",
                        "研究团队",
                        "公募基金",
                        "持仓"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}